Unknown

Dataset Information

0

The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.


ABSTRACT: The ongoing pandemic of COVID-19 alongside the outbreaks of SARS in 2003 and MERS in 2012 underscore the significance to understand betacoronaviruses as a global health challenge. SARS-CoV-2, the etiological agent for COVID-19, has infected over 50 million individuals' worldwide with more than ?1 million fatalities. Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks urge for better understanding of viral subversion of autophagy. Using MHV-A59 as a model betacoronavirus, time-course infections revealed significant loss in the protein level of ULK1, a canonical autophagy-regulating kinase, and the concomitant appearance of a possible cleavage fragment. To investigate whether virus-encoded proteases target ULK1, we conducted in-vitro and cellular cleavage assays and identified ULK1 as a novel bona fide substrate of SARS-CoV-2 papain-like protease (PLpro). Mutagenesis studies discovered that ULK1 is cleaved at a conserved PLpro recognition sequence (LGGG) after G499, separating its N-terminal kinase domain from a C-terminal substrate recognition region. Over-expression of SARS-CoV-2 PLpro is sufficient to impair starvation-induced autophagy and disrupt formation of ULK1-ATG13 complex. Finally, we demonstrated a dual role for ULK1 in MHV-A59 replication, serving a pro-viral functions during early replication that is inactivated at late stages of infection. In conclusion, our study identified a new mechanism by which PLpro of betacoronaviruses induces viral pathogenesis by targeting cellular autophagy.

SUBMITTER: Mohamud Y 

PROVIDER: S-EPMC7836930 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.

Mohamud Yasir Y   Xue Yuan Chao YC   Liu Huitao H   Ng Chen Seng CS   Bahreyni Amirhossein A   Jan Eric E   Luo Honglin H  

Biochemical and biophysical research communications 20210108


The ongoing pandemic of COVID-19 alongside the outbreaks of SARS in 2003 and MERS in 2012 underscore the significance to understand betacoronaviruses as a global health challenge. SARS-CoV-2, the etiological agent for COVID-19, has infected over 50 million individuals' worldwide with more than ∼1 million fatalities. Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks urge for better understanding of viral subversion of autophagy.  ...[more]

Similar Datasets

| S-EPMC7453225 | biostudies-literature
| S-EPMC9243667 | biostudies-literature
| S-EPMC5562857 | biostudies-literature
| S-EPMC8080724 | biostudies-literature
| S-EPMC1462710 | biostudies-other
| S-EPMC4530630 | biostudies-literature
| S-EPMC6351106 | biostudies-literature
| S-EPMC3587229 | biostudies-literature
| S-EPMC3059221 | biostudies-literature
| S-EPMC3606318 | biostudies-literature